Request that the FDA determine whether Rectiv® (nitroglycerin) Ointment 0.4%; NDA 021359 of ABBVIE INC has been voluntarily withdrawn from sale | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-2026-P-4566

Request that the FDA determine whether Rectiv® (nitroglycerin) Ointment 0.4%; NDA 021359 of ABBVIE INC has been voluntarily withdrawn from sale

Documents

Comments

Description

CLOSED

Key Dates

Comment Period OpensApr 24, 2026

Documents

Type	Title	Posted	Comments	Status
Other	Response Letter	Jun 26, 2026	--

Keywords

CDER

Citizen Petition

Aurobindo Pharma USA, Inc.

determine whether Rectiv (nitroglycerin)

Ointment 0.4%; NDA 021359 of

ABBVIE INC has been

voluntarily withdrawn from sale

CLOSED

Data from Regulations.gov